TLDR Athletes can experience various skin injuries from physical activity and environmental factors, and performance-enhancing drugs can also negatively affect their skin.
The document "Cutaneous Manifestations of Disease in Athletes" from 2002 examined various types of skin injuries in athletes, focusing on mechanical injuries such as corns, calluses, talon noir (calcaneal petechiae), tennis toe, jogger's nipples, and piezogenic pedal papules. It also discussed environmental factors that can affect athletes' skin both during and years after competition. The paper concluded with a discussion on the impact of performance-enhancing drugs on athletes' skin and how practitioners can potentially prevent the long-term effects of drug abuse.
2 citations,
December 2023 in “International journal of molecular sciences” Understanding keratinization is crucial for treating skin conditions like ichthyoses and psoriasis.
34 citations,
September 2020 in “BMC Endocrine Disorders” Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.
32 citations,
April 2013 in “Anais Brasileiros de Dermatologia” The document concludes that inherited epidermolysis bullosa is a challenging genetic condition requiring multidisciplinary care and new treatments.
76 citations,
December 2018 in “Aesthetic Plastic Surgery” Platelet-rich plasma may help in skin and hair treatments, and with muscle and joint healing, but more research is needed to fully understand its benefits and limitations.
30 citations,
May 2014 in “American Journal of Clinical Dermatology” The conclusion is that better understanding and more research are needed to effectively manage follicular and scarring disorders in skin of color, with an emphasis on patient education and cultural awareness.
